phillygenin and Acute-Lung-Injury

phillygenin has been researched along with Acute-Lung-Injury* in 1 studies

Other Studies

1 other study(ies) available for phillygenin and Acute-Lung-Injury

Article	Year
Phillygenin inhibits the inflammation and apoptosis of pulmonary epithelial cells by activating PPARγ signaling via downregulation of MMP8. Molecular medicine reports, 2021, Volume: 24, Issue:5 Acute lung injury (ALI) is often responsible for the high morbidity of critically ill patients. The present study aimed to investigate whether phillygenin (PHI) can inhibit inflammation and apoptosis of pulmonary epithelial cells by activating peroxisome proliferator‑activated receptor γ (PPARγ) signaling. The Topics: Acute Lung Injury; Anti-Inflammatory Agents; Apoptosis; Cell Line; Child; Child, Preschool; Epithelial Cells; Female; Humans; Inflammation; Lignans; Male; Matrix Metalloproteinase 8; PPAR gamma	2021

Article

Year

Phillygenin inhibits the inflammation and apoptosis of pulmonary epithelial cells by activating PPARγ signaling via downregulation of MMP8.

Molecular medicine reports, 2021, Volume: 24, Issue:5

Acute lung injury (ALI) is often responsible for the high morbidity of critically ill patients. The present study aimed to investigate whether phillygenin (PHI) can inhibit inflammation and apoptosis of pulmonary epithelial cells by activating peroxisome proliferator‑activated receptor γ (PPARγ) signaling. The

Topics: Acute Lung Injury; Anti-Inflammatory Agents; Apoptosis; Cell Line; Child; Child, Preschool; Epithelial Cells; Female; Humans; Inflammation; Lignans; Male; Matrix Metalloproteinase 8; PPAR gamma

2021